Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.

about

Liquid biopsy provides new insights into gastric cancer.Biomarkers of gastric cancer: Current topics and future perspective

P2860

Q52620413-A591ADF7-6050-4EA4-9522-8C7F5FD25FCE Q57176090-24E0A839-B92A-4F67-92CA-B5B7FC60BD56

P2860

Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.

Item

http://www.wikidata.org/entity/Q50642054

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Detection of HER2 Amplificatio ...... ative Gastric Cancer Patients.

@en

Detection of HER2 Amplificatio ...... ative Gastric Cancer Patients.

@nl

type

Item

label

Detection of HER2 Amplificatio ...... ative Gastric Cancer Patients.

@en

Detection of HER2 Amplificatio ...... ative Gastric Cancer Patients.

@nl

prefLabel

Detection of HER2 Amplificatio ...... ative Gastric Cancer Patients.

@en

Detection of HER2 Amplificatio ...... ative Gastric Cancer Patients.

@nl

P1476

Detection of HER2 Amplificatio ...... ative Gastric Cancer Patients.

@en

P2093

Harumi Shibata

http://www.w3.org/2001/XMLSchema#string

Keisho Chin

http://www.w3.org/2001/XMLSchema#string

Kiyohiko Hatake

http://www.w3.org/2001/XMLSchema#string

Mariko Mikuniya

http://www.w3.org/2001/XMLSchema#string

Mariko Ogura

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Mizunuma

http://www.w3.org/2001/XMLSchema#string

Ryoko Kuniyoshi

http://www.w3.org/2001/XMLSchema#string

Satoshi Matsusaka

http://www.w3.org/2001/XMLSchema#string

Sayuri Minowa

http://www.w3.org/2001/XMLSchema#string

Tomoko Takayama

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

HER2 testing in gastric cancer: a practical approach

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.

Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma.

The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.

P2888

s11523-017-0493-6

P304

341-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11523-017-0493-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28508152

http://www.w3.org/2001/XMLSchema#string

Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.

about

P2860

P2860

Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698